Revista Alergia México (Nov 2014)

Mexican Guidelines on the Diagnosis and Treatment of Urticaria

  • Désirée Larenas-Linnemann,
  • Miguel Alejandro Medina-Ávalos,
  • José Antonio Ortega-Martell,
  • Angélica María Beirana-Palencia,
  • María Isabel Rojo-Gutiérrez,
  • Martha Alejandra Morales-Sánchez,
  • Héctor Solorio-Gómez,
  • María de Lourdes Alonzo-Romero Pareyón,
  • Jorge Bernardo Vargas-Correa,
  • Carlos Báez-Loyola,
  • Roberto Blancas-Espinosa,
  • Joaquín Esquer-Flores,
  • Javier Gómez-Vera,
  • María Graciela Guzmán-Perea,
  • Alejandra Macías-Weinmann,
  • César Alfonso Maldonado-García,
  • José Darío Martínez-Villarreal,
  • Juan José Matta-Campos,
  • Elías Medina-Segura,
  • Blanca Estela Del Río-Navarro,
  • Juan Ignacio Salgado-Gama,
  • Héctor Stone-Aguilar,
  • Juan José Luis Sienra-Monge,
  • Sandra Nora González-Díaz,
  • Enrique Mendoza-López,
  • Mario Amaya-Guerra,
  • Alicia Lemini-López,
  • Andrés Blanco-Montero,
  • María Teresa Chavarría-Jiménez,
  • Martha Graciela Guerrero-Michaus,
  • Albina Martínez-Pérez,
  • Ruth Ivonne Mireya Ramírez-Segura,
  • Gabriel Montes-Narváez,
  • Jorge Olvera-Salinas,
  • Ana Beatriz Rosas-Sumano

DOI
https://doi.org/10.29262/ram.v61i0.49
Journal volume & issue
Vol. 61, no. 0
pp. 117 – 93

Abstract

Read online

Background: Urticaria is a disease that a fth of the population shall suffer once in a lifetime. Recent clinical guidelines have proposed some fundamental changes in the diagnosis and treatment of urticaria, making the development of a national, multidisciplinary guideline, with wide acceptability among different professional groups –both specialists and primary health care workers–, necessary in Mexico. Material and method: Internationally recognized tools for guideline- development were used. An interdisciplinary group of clinical experts (some of them knowledgeable in methodology of guideline develop- ment) determined the objectives and scope of the Evidence Based Clinical Practice Guideline with SCOPE. It was decided to adapt and transculturize international guidelines on the diagnosis and treatment of urticaria. With AGREE-II three high-quality guidelines (Zuberbier 2014, Sánchez-Borges 2012, Powell 2007) were selected to function as basic guidelines (BG). A set of Clinical Questions was formulated that lead to recommendations/suggestions, based on these BG, taking into account the cultural and economic background of Mexico, according to GRADE recommendation development. Results: By a formal process of discussion and voting during several working-sessions, experts and rst level healthcare physicians deter- mined the wording of the nal guideline, taking particularly care of developing a document, adjusted to the reality, values and preferences of the Mexican patients. The use of oral second generation, non-sedating antihistamines as rst line treatment is emphasized. Conclusion: This document is an Evidence Based Clinical Practice Guideline for the diagnosis and treatment of acute and chronic urticaria, based on three, high quality, international guidelines. It was developed by a multidisciplinary group. Tables and algorithms make the guideline user-friendly for both, rst line health care physicians and specialists

Keywords